BioSpace News Archive

ASG Superconductors and Siemens Healthineers join forces to deliver 10.5T Ultra High Field MRI Systems for ground-breaking brain research

ASG Superconductors and Siemens Healthineers signed a partnership agreement to synergistically develop UHF MRI systems of unprecedented dependability for ground-breaking brain research.

January 18, 2023
·
2 min read
BioMidwest

Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS

Natus Medical Incorporated announced the closing of its acquisition of Micromed Holding SAS, a global provider of neurophysiology solutions.

January 18, 2023
·
3 min read
Business

NUROSENE ANNOUNCES ADVISORY ROLE WITH RARE-X

Nurosene Health Inc. is pleased to announce an advisory relationship with RARE-X, the Global Genes collaborative platform for rare disease patients to share their data to accelerate the development of diagnoses and treatments.

January 18, 2023
·
5 min read
Business

Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies

Zomedica Corp. today announced a strategic restructuring of its existing development and commercialization agreements with Qorvo Biotechnologies for the Company’s TRUFORMA line of products.

January 18, 2023
·
7 min read
Business

Dr. Sandra Lee (AKA Dr. Pimple Popper) Joins Sun Pharma Awareness Campaign to Spotlight the Role of Hormones in the Skin as an Underlying Cause of Acne

Sun Pharmaceutical Industries, Inc. today announced the launch of “AH-ha!™ It’s Acne Hormones,” an awareness campaign featuring board-certified dermatologist Dr. Sandra Lee.

January 18, 2023
·
3 min read
Business

APRINOIA Therapeutics and ROSS Acquisition Corp II Announce Business Combination Agreement to Create Publicly Listed Company Focused on Neurodegenerative Diseases

APRINOIA Therapeutics Inc. and Progressive Supranuclear Palsy (“PSP”), and Ross Acquisition Corp II today announced that they have entered into a definitive agreement (the “Business Combination Agreement”) for a business combination (the “Business Combination”).

January 18, 2023
·
15 min read
Drug Development

Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2

Monopar Therapeutics Inc. today announced the positive recommendation from its safety review committee to advance to the fifth dose level (650 mg/m 2 ) in its camsirubicin Phase 1b trial in patients with advanced soft tissue sarcoma (ASTS).

January 18, 2023
·
5 min read
FDA

FDA approves Orthogen’s IDE

Orthogen AG , a leader in molecular medicine, announces U.S. Food and Drug Administration (FDA) approval of an Investigational Device Exemption (IDE) for the company’s proprietary technology, Orthogen® Device (OD).

January 18, 2023
·
2 min read
Pharm Country

Krystal Biotech Receives European Commission Orphan Designation for KB407 for the Treatment of Cystic Fibrosis

Krystal Biotech, Inc. announced today that the European Commission has granted orphan designation for KB407 for the treatment of Cystic Fibrosis (CF).

January 18, 2023
·
3 min read
Drug Development

Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial Spondyloarthritis

UCB, a global biopharmaceutical company, today announced that Annals of the Rheumatic Diseases has published 24-week results from the Phase 3 BE MOBILE 1 and BE MOBILE 2 studies.

January 18, 2023
·
10 min read